Skip to main content
Clinical Trials/NL-OMON46205
NL-OMON46205
Completed
Phase 2

A follow-up study to investigate the functionality of a glucose sensor device in the human eye. - NSGSIIb

oviosense BV0 sites24 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Diabetes type 1
Sponsor
oviosense BV
Enrollment
24
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
oviosense BV

Eligibility Criteria

Inclusion Criteria

  • \* Subject is \> 18 years old on the date he/she signed the informed consent;
  • \* Diagnosed diabetes type 1;
  • \* Insulin dependent;
  • \* Wearing FreeStyle Libre CGM device;
  • \* Signed informed consent.

Exclusion Criteria

  • \* Subjects having any eye surgery in the past;
  • \* Subjects having any historic disease of the eye (e.g. conjunctivitis, keratitis, dry eye, diabetic retinopthy with lasercoagulation);
  • \* Subjects that wear contact lenses;
  • \* Not able or willing to comply to the protocol;
  • \* Subjects with signs/ symptoms of any additional disease except diabetes (medical judgement and/or medication history).

Outcomes

Primary Outcomes

Not specified

Similar Trials